Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Updated 06/21/2024

Status Completed

Clinical Trial Summary

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Clinical Trial Description

A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03812510
Study type	Interventional
Source	Aclaris Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	February 7, 2019
Completion date	December 20, 2019

See also
	Status	Clinical Trial	Phase
	Suspended	`NCT01796795` - Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients	Phase 2
	Completed	`NCT03687372` - Study of A-101 Topical Solution for the Treatment of Common Warts	Phase 3
	Completed	`NCT03691831` - A Study of A-101 Topical Solution for the Treatment of Common Warts	Phase 3
	Completed	`NCT00328991` - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts	N/A
	Completed	`NCT05115669` - Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts	N/A
	Completed	`NCT03487549` - Cantharidin and Occlusion in Verruca Epithelium	Phase 2
	Not yet recruiting	`NCT04288817` - Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts	Phase 3
	Active, not recruiting	`NCT05896215` - OM202JP Clinical Study of KNP2002	Phase 2
	Completed	`NCT03278028` - A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts	Phase 2
	Recruiting	`NCT05799157` - Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts	Phase 2
	Recruiting	`NCT06214559` - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.	N/A
	Recruiting	`NCT03977753` - Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts	Phase 4
	Completed	`NCT03183765` - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts	Phase 4
	Completed	`NCT03210337` - A Phase2 of A-101 Topical Solution in Subjects With Common Warts	Phase 2